ÂÜÀòÂÒÂ×

Oliver Fuhrmann is an accomplished executive with extensive experience in the clinical research sector, currently serving as Executive Vice President at Parexel since October 2006. Fuhrmann holds roles such as Global Head Early Phase Development and Regional Head Europe for Clinical Innovation, alongside leadership positions in the Enterprise Account Group. Prior to this, Fuhrmann gained valuable experience as a Research Fellow at Charité, focusing on clinical research in infectious diseases and internal medicine. Educational qualifications include a Ph.D. from Humboldt-Universität zu Berlin and a Diplom/Master in Biology from Justus Liebig University Giessen.